REFERENCES
- Ferrer F A, Isakoff M, Koyle M A. Bladderprostate rhabdomyosarocma: past, present and future [review article]. T J Urol 2006; 176(4)1283–1291
- Fletcher C DM, Unni K K, Mertens F. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone. IARC Press, Lyon 2002
- Crist W M, Garnsey L, Beltangady M S, et al. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 1990; 8(3)443–452
- Crist W, Gehan E A, Ragab A H, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13(3)610–630
- Lawrence W, Jr., Gehan E A, Hays D M, et al. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from, the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 1987; 5(1)46–54
- Lawrence W, Jr., Anderson J R, Gehan E A, , Pretreatment T NM, et al. staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Cancer 1997; 80(6)1165–1170
- Raney R B, Anderson J R, Barr F G, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 2001; 23(4)215–220
- Breneman J C, Lyden E, Pappo A S, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21(1)78–84